Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study

Misbah Noshela Ghazanfar; Ewa Anna Bartko; Nicolai Skovbjerg Arildsen; Lars K. Poulsen; Bettina Margrethe Jensen; Christian Enevold; Jesper Grønlund Holm; Anders Woetmann; Niels Ødum; Simon Francis Thomsen

doi:10.1111/cea.14121

Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study

Misbah Noshela Ghazanfar^*, Ewa Anna Bartko, Nicolai Skovbjerg Arildsen, Lars K. Poulsen, Bettina Margrethe Jensen, Christian Enevold, Jesper Grønlund Holm, Anders Woetmann, Niels Ødum, Simon Francis Thomsen

^*Corresponding author for this work

1 Citation (Scopus)

Original language	English
Journal	Clinical and Experimental Allergy
Volume	52
Issue number	5
Pages (from-to)	715-718
Number of pages	4
ISSN	0954-7894
DOIs	https://doi.org/10.1111/cea.14121
Publication status	Published - May 2022

Keywords

Anti-Allergic Agents/therapeutic use
Chronic Disease
Chronic Urticaria/drug therapy
Humans
Omalizumab/therapeutic use
Prospective Studies
Treatment Outcome
Urticaria/diagnosis

Access to Document

10.1111/cea.14121

Cite this

Ghazanfar, M. N., Bartko, E. A., Arildsen, N. S., Poulsen, L. K., Jensen, B. M., Enevold, C., Holm, J. G., Woetmann, A., Ødum, N., & Thomsen, S. F. (2022). Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study. Clinical and Experimental Allergy, 52(5), 715-718. https://doi.org/10.1111/cea.14121

@article{72e58e8c49724d059e7b650a679381cd,

title = "Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study",

keywords = "Anti-Allergic Agents/therapeutic use, Chronic Disease, Chronic Urticaria/drug therapy, Humans, Omalizumab/therapeutic use, Prospective Studies, Treatment Outcome, Urticaria/diagnosis",

author = "Ghazanfar, {Misbah Noshela} and Bartko, {Ewa Anna} and Arildsen, {Nicolai Skovbjerg} and Poulsen, {Lars K.} and Jensen, {Bettina Margrethe} and Christian Enevold and Holm, {Jesper Gr{\o}nlund} and Anders Woetmann and Niels {\O}dum and Thomsen, {Simon Francis}",

year = "2022",

month = may,

doi = "10.1111/cea.14121",

language = "English",

volume = "52",

pages = "715--718",

journal = "Clinical Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria

T2 - A three-month prospective study

AU - Ghazanfar, Misbah Noshela

AU - Bartko, Ewa Anna

AU - Arildsen, Nicolai Skovbjerg

AU - Poulsen, Lars K.

AU - Jensen, Bettina Margrethe

AU - Enevold, Christian

AU - Holm, Jesper Grønlund

AU - Woetmann, Anders

AU - Ødum, Niels

AU - Thomsen, Simon Francis

PY - 2022/5

Y1 - 2022/5

KW - Anti-Allergic Agents/therapeutic use

KW - Chronic Disease

KW - Chronic Urticaria/drug therapy

KW - Humans

KW - Omalizumab/therapeutic use

KW - Prospective Studies

KW - Treatment Outcome

KW - Urticaria/diagnosis

UR - http://www.scopus.com/inward/record.url?scp=85126838148&partnerID=8YFLogxK

U2 - 10.1111/cea.14121

DO - 10.1111/cea.14121

M3 - Letter

C2 - 35278253

AN - SCOPUS:85126838148

VL - 52

SP - 715

EP - 718

JO - Clinical Allergy

JF - Clinical Allergy

SN - 0954-7894

IS - 5

ER -

Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study

Keywords

Access to Document

Other files and links

Cite this